LGND

Ligand Pharmaceuticals Incorporated News Headlines

$53.0018
*  
1.2118
2.34%
Get LGND Alerts
*Delayed - data as of Dec. 26, 2014 15:34 ET  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LGND Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cyclacel Provides SEAMLESS Study Update on Sapacitabine - Analyst Blog
10/14/2014 5:25:00 PM - Zacks.com


AbbVie's Humira Positive in Late-Stage Skin Disease Study - Analyst Blog
10/14/2014 5:05:00 PM - Zacks.com


Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
10/14/2014 5:00:00 PM - Zacks.com


Alnylam Jumps on Positive Patisiran Data from Phase II Study - Analyst Blog
10/14/2014 3:45:00 PM - Zacks.com


NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape
10/14/2014 8:46:00 AM - Zacks.com


Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog
10/13/2014 4:55:00 PM - Zacks.com


Prosensa Starts Rolling NDA Submission for Drisapersen - Analyst Blog
10/13/2014 4:30:00 PM - Zacks.com


Targacept's Nine-Year Association with AstraZeneca to End - Analyst Blog
10/13/2014 3:00:00 PM - Zacks.com


Will Johnson & Johnson Beat Earnings on Pharma Sales? - Analyst Blog
10/13/2014 11:50:00 AM - Zacks.com


Insider Buys And Sells: SFX Entertainment, SunPower Corporation
10/13/2014 10:49:00 AM - Seeking Alpha


Weakness Seen in Momenta Pharmaceuticals (MNTA): Stock Tumbles 13.5% - Tale of the Tape
10/13/2014 7:30:00 AM - Zacks.com


AstraZeneca's Benralizumab Encourages in Phase II Study - Analyst Blog
10/10/2014 4:52:00 PM - Zacks.com


XOMA Starts Phase I Study on XOMA 358 for Hyperinsulinism - Analyst Blog
10/10/2014 4:10:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 10/9/14: LGND, ALSN, IVAC, WWWW
10/10/2014 10:05:00 AM - Seeking Alpha


Ligand Provides Better-than-Expected Q3 Earnings Guidance - Analyst Blog
10/9/2014 3:10:00 PM - Zacks.com


Amgen Up on Positive Phase III Data on Psoriasis Biosimilar - Analyst Blog
10/9/2014 2:54:00 PM - Zacks.com


Dow Surges Over 200 Points After FOMC Minutes; Blackhawk Shares Jump On Strong Results
10/8/2014 2:40:01 PM - Benzinga


Interface Drops On Q3 Warning; Symantec Shares Rise
10/8/2014 1:03:08 PM - Benzinga


Update: Ligand Reports Expected Q3 Revenues
10/8/2014 12:55:00 PM - Seeking Alpha


Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog
10/7/2014 4:40:00 PM - Zacks.com


Eli Lilly Stops Developing Tabalumab Due to Efficacy Issues - Analyst Blog
10/7/2014 4:30:00 PM - Zacks.com


AbbVie's Humira Label Expanded in U.S. - Analyst Blog
10/7/2014 4:05:00 PM - Zacks.com


Insiders Now Seeing Red With LGND At New 52-Week Low
10/7/2014 12:14:25 PM - BNK Invest


Ligand Earns Milestone Payment on EU Approval of Noxafil - Analyst Blog
10/2/2014 12:00:00 PM - Zacks.com


Update: Ligand Augments Captisol Platform
9/26/2014 1:35:00 PM - Seeking Alpha